Retrospective assessment of hypercoagulability in breast cancer prevention trial.
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001778:Blood Coagulation Disorders / Q000139:chemically induced* / Q000209:etiology; D001943:Breast Neoplasms / Q000517:prevention & control*; D005260:Female; D006801:Humans; D012189:Retrospective Studies; D013629:Tamoxifen / Q000009:adverse effects*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen